What You Missed in 2025
This is your chance to learn directly from industry leaders at Allogene, Genentech, NKILT, ImmuneBridge, and more as they reveal how they’re identifying ‘super donors’ and using advanced assays to boost product consistency and performance. Walk away with proven strategies to reduce variability, de-risk manufacturing, and strengthen your allogeneic pipeline from the start.
Whether you're starting to build a donor screening program or scaling up an existing strategy, this is the only event dedicated to accelerating growth in the cell therapy space by tackling its starting material. We’re bringing together experts from process development, analytical development, supply chain, cryopreservation, and C-level executives to present practical, cross-functional takeaways you can apply immediately to accelerate timelines, cut costs, and meet clinical demand.
What to Expect?
2 Days of Unmissable Content
Including new data & actionable insights from from allogeneic leaders
8+ Hours of Networking
And interactive discussion-led sessions to develop critical solutions to the most pressing challenges
14 Brand New Speakers
Across analytical development, supply chain, logistics, cryopreservation, and R&D teams
This Summit Had the Opportunity to:
Donor Profiles to Streamline Recruitment
What really defines a “super donor”? You joined NKore BioTherapeutics and Genentech to explore intra-donor variability and how lifestyle and motivation factors may be just as important as biomarkers. You challenged outdated assumptions and learnt how building more inclusive, high-performing donor pools can reduce sourcing bottlenecks and make recruitment a smoother process.
Build Smarter Donor Strategies and Tackle Variability at the Source
You got practical, real-world insights from ImmuneBridge, Luminary Therapeutics, NKILT Therapeutics and more as they revealed how they’re screening, ranking, and retaining optimal donors. From computational analytics to new data on variability, you walked away with actionable strategies to streamline donor selection, improve yield, and accelerate more scalable manufacturing.
Turn Donor Strategy into a Competitive Edge
You heard how Allogene and others are turning their donor strategy into a true value proposition. Whether you were looking to impress investors or scale with confidence, this was your chance to learn how smarter donor programs can give you the leading edge.
Safeguard Material Quality with Smarter Supply Chain Solutions
You learnt how Genentech and Bristol Myers Squibb tackled long-term donor access and reducing batch failures by advancing recallability, cryopreservation, and other logistics strategies. Attendees left with practical tools to protect consistency and keep their operations moving as they scaled.
Explore the 2025 Event Guide
- Tools to nail characterization testing with insights from Immunebridge
- Insights into the investment landscape from Allogene Therapeutics
- Real data on how other companies like Luminary Therapeutics and Genentech are using starting material
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.